J. Devincenzo

发表

Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses

C. Beauchemin, Young-In Kim, G. Ciaramella, 2019, PloS one.

Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification

Kendra N. Pesko, Todd M. Allen, J. Levin, 2012, Nucleic acids research.

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

Rob Lambkin-Williams, E. Walsh, J. Gollob, 2010, Proceedings of the National Academy of Sciences.

Viral load drives disease in humans experimentally infected with respiratory syncytial virus.

J. Oxford, Rob Lambkin-Williams, A. Mann, 2010, American journal of respiratory and critical care medicine.

Oral GS-5806 activity in a respiratory syncytial virus challenge study.

Rob Lambkin-Williams, S. Lewis, R. Jordan, 2014, The New England journal of medicine.

Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus

Young-In Kim, R. Álvarez, J. Devincenzo, 2014, PloS one.

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

A. Randolph, T. Bhangale, P. Thomas, 2017, Nature Medicine.

The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.

J. Devincenzo, J. DeVincenzo, 2012, Antiviral Therapy.

Changes in mandibular length before, during, and after successful orthopedic correction of Class II malocclusions, using a functional appliance.

J. Devincenzo, J. DeVincenzo, John P. Devincenzo, 1991, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

A study in human subjects using a new device designed to mimic the protrusive functional appliances used previously in monkeys.

J. Devincenzo, R. Huffer, M. W. Winn, 1987, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

Mucosal Immune Responses Predict Clinical Outcomes during In fl uenza Infection Independently of Age and Viral Load Christine

T. Hertz, P. Thomas, Sook-San Wong, 2014 .

Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

R. Webby, T. Hertz, P. Thomas, 2014, American journal of respiratory and critical care medicine.

SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

E. Simões, R. Yogev, C. Ambrose, 2019, American Journal of Perinatology.

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.

C. Byington, W. Schaffner, R. Karron, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

E. Simões, C. Ambrose, P. Pannaraj, 2016, American Journal of Perinatology.

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants

Doris Makari, C. Ambrose, J. Devincenzo, 2016, Human vaccines & immunotherapeutics.

Respiratory syncytial virus infections in the pediatric intensive care unit: Clinical characteristics and risk factors for adverse outcomes

A. Bush, M. Quasney, J. Devincenzo, 2001, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Risk Factors for Severe Respiratory Syncytial Virus Disease in Children With Cancer: The Importance of Lymphopenia and Young Age

G. Somes, J. Devincenzo, A. Gaur, 2008, Pediatrics.

A COVID‐19 human viral challenge model. Learning from experience

Rob Lambkin-Williams, J. Devincenzo, 2020, Influenza and other respiratory viruses.

Prolonged thalidomide therapy for human immunodeficiency virus-associated recurrent severe esophageal and oral aphthous ulcers.

J. Devincenzo, S. K. Burchet, J. DeVincenzo, 1996, The Pediatric infectious disease journal.

Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans

Qingling Zhang, D. Huntjens, J. Symons, 2018, The Journal of antimicrobial chemotherapy.

Comparing molecular quantification of herpes simplex virus (HSV) in cerebrospinal fluid (CSF) with quantitative structural and functional disease severity in patients with HSV encephalitis (HSVE): Implications for improved therapeutic approaches.

Anami R Patel, N. Lenny, M. Koçak, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Natural Infection of Infants with Respiratory Syncytial Virus Subgroups A and B: A Study of Frequency, Disease Severity, and Viral Load

J. Devincenzo, J. DeVincenzo, 2004, Pediatric Research.

Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity

J. Devincenzo, S. Cormier, Dahui You, 2020, BMC Microbiology.

A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome.

O. Ramilo, H. Jafri, A. Bush, 2002, The Journal of infectious diseases.

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein

Young-In Kim, L. Wilson, J. Devincenzo, 2019, Antimicrobial Agents and Chemotherapy.

Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33

Tamekia Jones, B. Bagga, J. Devincenzo, 2015, PLoS pathogens.

Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants

J. Devincenzo, L. Harrison, Jody A Aitken, 2015, Clinical microbiology.

A new direction in understanding the pathogenesis of respiratory syncytial virus bronchiolitis: how real infants suffer.

J. Devincenzo, J. DeVincenzo, 2007, The Journal of infectious diseases.

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

P. Dormitzer, C. Russell, J. Devincenzo, 2014, Vaccine.

A COVID‐19 human viral challenge model. Learning from experience

Rob Lambkin-Williams, J. Devincenzo, J. DeVincenzo, 2020, Influenza and other respiratory viruses.

Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults.

E. Walsh, B. Bagga, J. Devincenzo, 2015, The Journal of infectious diseases.

Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe RSV Bronchiolitis.

Tamekia Jones, J. Devincenzo, S. Cormier, 2019, American journal of respiratory and critical care medicine.

Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).

J. Devincenzo, 1997, Advances in pediatric infectious diseases.

Time and out-of-pocket costs associated with respiratory syncytial virus hospitalization of infants.

J. Marcin, J. Devincenzo, Harry Yang, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience

R. Hirsch, J. Devincenzo, F. H. Top, 2000, Bone Marrow Transplantation.

Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus

Doris Makari, J. Devincenzo, P. Checchia, 2013, Human vaccines & immunotherapeutics.

Respiratory Syncytial Virus Disease Severity is Associated with Distinct CD8+ T Cell Profiles.

Tamekia Jones, J. Devincenzo, S. Cormier, 2020, American journal of respiratory and critical care medicine.

Do asymptomatic respiratory viral infections occur?

J. Devincenzo, Lisa G Harrison, E. Meals, 2018, Journal of Clinical Virology.

Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study

D. Roymans, Young-In Kim, D. Huntjens, 2018, The Journal of infectious diseases.

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

Rob Lambkin-Williams, A. Gilbert, H. Schuitemaker, 2021, The Journal of infectious diseases.

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.

P. Collins, U. Buchholz, J. Devincenzo, 2014, The Journal of clinical investigation.

Effect of dexamethasone on respiratory syncytial virus‐induced lung inflammation in children: results of a randomized, placebo controlled clinical trial

O. Ramilo, A. Mejias, H. Jafri, 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Group B streptococcal ventriculitis: a report of three cases and literature review.

J. Devincenzo, Isao Miyairi, S. Buckingham, 2006, Pediatric neurology.

Respiratory syncytial virus load and disease severity in the community

J. Devincenzo, C. E. El Saleeby, 2011, Journal of medical virology.

Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV

S. Lewis, R. Jordan, T. Cihlar, 2020 .

Factors Predicting Childhood Respiratory Syncytial Virus Severity: What They Indicate About Pathogenesis

J. Devincenzo, J. DeVincenzo, 2005, The Pediatric infectious disease journal.

The antiviral effects of RSV fusion inhibitor, MDT‐637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin

Young-In Kim, J. Devincenzo, Lisa G Harrison, 2017, Influenza and other respiratory viruses.

Results of a phase 2b multi-center trial of ALN-RSV01 in respiratory syncytial virus (RSV)-infected lung transplant patients

M. Zamora, J. Gollob, J. Gottlieb, 2012 .

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.

B. Bettencourt, M. Zamora, J. Gollob, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Respiratory Syncytial Virus Infections in Hematopoietic Stem Cell Transplant Recipients and other Severely Immunocompromised Patients

J. Devincenzo, J. DeVincenzo, 2000 .

Emerging and newly identified viral infections.

J. Devincenzo, 1996, Pediatric annals.

Passive antibody prophylaxis for RSV.

J. Devincenzo, J. DeVincenzo, 2008, The Pediatric infectious disease journal.

Traumatic Lumbar Puncture is Unlikely to Reduce Modern Molecular Detection of HSV Encephalitis (HSVE)

Anami R Patel, N. Lenny, J. Devincenzo, 2018 .

Confounding by Indication Limits Conclusions of Study of Palivizumab Effectiveness

R. Yogev, J. Devincenzo, L. Krilov, 2017, Pediatrics.

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.

S. Madhi, M. P. Griffin, E. Simões, 2020, The New England journal of medicine.

Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study

Kazuhiro Ito, P. Strong, J. Devincenzo, 2020, The Journal of infectious diseases.

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein

Young-In Kim, L. Wilson, J. Devincenzo, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease.

J. Burns, J. Connor, E. Capparelli, 2003, Current therapeutic research, clinical and experimental.

, with Respiratory Syncytial Virus Viral Load in Children Naturally Infected Technique for Quantitative Assessment of Transcriptase PCR Assay and a Culture Comparison of a Real-Time Reverse

Anami R Patel, J. Devincenzo, S. Perkins, 2005 .

Therapy of respiratory syncytial virus infection.

J. Devincenzo, J. DeVincenzo, 2000, The Pediatric infectious disease journal.

An organ culture technique for maintaining the pulp tissue of intact human teeth.

J. Devincenzo, J. DeVincenzo, 1968, Experimental cell research.

A new in vitro technique for studies on tooth permeability.

J. Devincenzo, L. Smith, 1968, Archives of oral biology.

A SELF-CONTAINED, INDWELLING CONTINUOUS FLOW APPARATUS DESIGNED FOR INTRA-ORAL RESEARCH.

J. Devincenzo, D. Jeffries, 1965, Archives of oral biology.

Angiostrongylus cantonensis Eosinophilic Meningitis in an Infant, Tennessee, USA

J. Noh, B. Bagga, Y. Qvarnstrom, 2017, Emerging infectious diseases.

Classification of Neurodevelopmental Age in Normal Infants Using 3D-CNN based on Brain MRI

Hao Chen, Mahdieh Shabanian, Eugene C. Eckstein, 2019, 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

Determination of picogram amounts of ATP using the luciferin-luciferase enzyme system.

J. Devincenzo, G. Lyman, J. DeVincenzo, 1967, Analytical biochemistry.

SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN

Rosanna Lagos, G. Losonsky, J. Suzich, 2009, The Pediatric infectious disease journal.

Mild herpes simplex encephalitis diagnosed by polymerase chain reaction: a case report and review.

J. Devincenzo, G. Thorne, 1994, The Pediatric Infectious Disease Journal.

Within-Host Whole-Genome Deep Sequencing and Diversity Analysis of Human Respiratory Syncytial Virus Infection Reveals Dynamics of Genomic Diversity in the Absence and Presence of Immune Pressure

Ruchi M. Newman, J. Levin, M. Zody, 2014, Journal of Virology.

Use of real-time semiquantitative PCR data in management of a neonatal intensive care unit adenovirus outbreak

Anami R Patel, S. Arnold, J. Devincenzo, 2018, Infection Control & Hospital Epidemiology.

Oerskovia xanthineolytica peritonitis: case report and review.

J. Devincenzo, J. Luján-Zilbermann, D. Jones, 1999, The Pediatric infectious disease journal.

The Eureka Spring™: a compact, versatile, and costeffective Class II corrector

J. Devincenzo, J. DeVincenzo, 2006 .

Maxillary incisor intrusion and facial growth.

J. Devincenzo, M. W. Winn, J. DeVincenzo, 2009, The Angle orthodontist.

A cephalometric study of the Class II correction effects of the Eureka Spring.

J. Devincenzo, J. Caruso, Ernest L Stromeyer, 2002, The Angle orthodontist.

Escherichia coli Sequence Type 131 Lineage C1-M27 Clone in Clinical Isolates, Germany

Bindiya, J. Noh, Y. Qvarnstrom, 2017 .

N-Linked Glycan at Residue 523 of Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Masks a Second Receptor-Binding Site

G. Taylor, V. Mishin, Makiko Watanabe, 2010, Journal of Virology.

Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.

J. Devincenzo, J. DeVincenzo, 2009, Early human development.

RNA interference therapy in lung transplant patients infected with respiratory syncytial virus.

M. Zamora, A. Humar, J. Gollob, 2011, American journal of respiratory and critical care medicine.

Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

A. Bush, J. Devincenzo, Chadi M El Saleeby, 2011, The Journal of infectious diseases.

Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States.

R. Jacobs, M. Jackson, J. Devincenzo, 2003, Archives of pediatrics & adolescent medicine.

Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States.

R. Jacobs, M. Jackson, J. Devincenzo, 2002, Archives of pediatrics & adolescent medicine.

Comparison of antiviral resistance across acute and chronic viral infections

J. Wu, S. Toovey, J. Devincenzo, 2018, Antiviral research.

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).

S. Elbashir, J. Harborth, I. Toudjarska, 2008, Antiviral research.

Rat Lungworm Infection Associated with Central Nervous System Disease — Eight U.S. States, January 2011–January 2017

S. Montgomery, B. Schwartz, M. Yabsley, 2018, MMWR. Morbidity and mortality weekly report.

Respiratory virus infections in pediatric hematopoietic stem cell transplantation.

J. Devincenzo, C. C. Patrick, J. Luján-Zilbermann, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to Respiratory Epithelium in a Viral Species- and Cell Type-Dependent Manner

R. Webby, G. Ulett, J. Devincenzo, 2006, Journal of Virology.

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

Svetlana Shulga Morskaya, M. Manoharan, M. Van Ranst, 2009, Antimicrobial Agents and Chemotherapy.

Comparison of a Real-Time Reverse Transcriptase PCR Assay and a Culture Technique for Quantitative Assessment of Viral Load in Children Naturally Infected with Respiratory Syncytial Virus

Anami R Patel, J. Devincenzo, S. Perkins, 2005, Journal of Clinical Microbiology.

The relation of the condylar path to the articular eminence in mandibular protrusion.

E. F. Shryock, J. Devincenzo, R. Huffer, 1971, The Angle orthodontist.

Multi-center evaluation of the adenovirus R-gene US assay for the detection of adenovirus in respiratory samples.

Anami R Patel, C. Ginocchio, N. Lenny, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection

N. Jojic, I. James, S. Mallal, 2012, Proceedings of the National Academy of Sciences.

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.

J. Kahn, P. Sánchez, N. Patel, 2004, The Journal of infectious diseases.

Assessing Modeled CO2 Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants

A. Patters, J. Devincenzo, J. Cehelsky, 2012, ISRN pediatrics.

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

J. Wrammert, C. D. de Haan, C. Chiu, 2015, American journal of respiratory and critical care medicine.

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

E. Walsh, F. Hayden, P. Griffiths, 2015, The Journal of infectious diseases.

RNA interference strategies as therapy for respiratory viral infections.

J. Devincenzo, J. DeVincenzo, 2008, The Pediatric infectious disease journal.

Respiratory Mucosal Proteome Quantification in Human Influenza Infections

K. Schughart, P. Thomas, R. Webby, 2016, PloS one.

ALS-008176 for Respiratory Syncytial Virus Infection.

J. Devincenzo, M. McClure, J. Fry, 2016, The New England journal of medicine.

Limited Type I Interferons and Plasmacytoid Dendritic Cells during Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis upon Reinfection

Young-In Kim, J. Devincenzo, S. Cormier, 2014, Journal of Virology.

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis

J. Devincenzo, R. Pickles, J. DeVincenzo, 2014, The Journal of pathology.

Human Genetic Factors and Respiratory Syncytial Virus Disease Severity

J. Devincenzo, I. Miyairi, J. DeVincenzo, 2008, Clinical Microbiology Reviews.

Compassionate use experience with high‐titer respiratory syncytical virus (RSV) immunoglobulin in RSV‐infected immunocompromised persons

E. Walsh, A. Falsey, J. Devincenzo, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody.

J. Devincenzo, Lisa G Harrison, Jody A Aitken, 2003, The Journal of pediatrics.

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.

O. Ramilo, W. Gruber, P. Sánchez, 1998, The Journal of infectious diseases.

Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population.

Rongling Li, Rongling Li, G. Somes, 2010, The Journal of pediatrics.

Masseter muscle position relative to dentofacial form.

J. Devincenzo, A. Proctor, 1970, The Angle orthodontist.

Orthopedic and orthodontic effects resulting from the use of a functional appliance with different amounts of protrusive activation.

J. Devincenzo, M. W. Winn, J. DeVincenzo, 1989, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

RSV and non-RSV illness hospitalization in RSV immunoprophylaxis recipients: A systematic literature review.

C. Ambrose, J. Devincenzo, L. Krilov, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores

D. Huntjens, J. Devincenzo, B. Green, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.

Ruchi M. Newman, M. Zody, X. Yang, 2017, Virology.

Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor

S. Hunt, Young-In Kim, Kazuhiro Ito, 2017, Antimicrobial Agents and Chemotherapy.

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study.

Rob Lambkin-Williams, Qingling Zhang, J. Symons, 2015, The New England journal of medicine.